Brief: Ipca Laboratories Says US FDA Conducted Inspection Of Co's Formulations Manufacturing Unit At Piparia
27/04/2023 04:21
April 27 (Reuters) - IPCA Laboratories Ltd IPCA.NS :
* US FDA CONDUCTED INSPECTION OF CO'S FORMULATIONS
MANUFACTURING
UNIT SITUATED AT PIPARIA
* US FDA ISSUED A FORM 483 WITH 3 OBSERVATIONS
Source text for Eikon: ID:nBSE3CFsKW
Further company coverage: IPCA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees